Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
28.78
+0.89 (3.19%)
At close: Jan 9, 2026, 4:00 PM EST
28.78
0.00 (0.00%)
After-hours: Jan 9, 2026, 4:10 PM EST
AAPG Stock Forecast
Stock Price Forecast
The 4 analysts that cover AAPG stock have a consensus rating of "Strong Buy" and an average price target of $48.5, which forecasts a 68.52% increase in the stock price over the next year. The lowest target is $45 and the highest is $51.
Price Target: $48.5 (+68.52%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 4, 2025.
Analyst Ratings
The average analyst rating for AAPG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $45 | Buy | Initiates | $45 | +56.36% | Dec 4, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $51 | Strong Buy | Initiates | $51 | +77.21% | Nov 24, 2025 |
| BTIG | BTIG | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +73.73% | Nov 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $48 | Buy | Initiates | $48 | +66.78% | Nov 5, 2025 |
| JP Morgan | JP Morgan | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 27, 2025 |
Financial Forecast
Revenue This Year
598.12M
from 980.65M
Decreased by -39.01%
Revenue Next Year
2.80B
from 598.12M
Increased by 368.64%
EPS This Year
-3.14
from -1.34
EPS Next Year
2.37
from -3.14
Financial currency is CNY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 766.5M | 3.4B | ||||
| Avg | 598.1M | 2.8B | ||||
| Low | 499.2M | 1.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -21.8% | 473.3% | ||||
| Avg | -39.0% | 368.6% | ||||
| Low | -49.1% | 198.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | -2.47 | 4.84 | ||
| Avg | -3.14 | 2.37 | ||
| Low | -3.68 | -0.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.